Improved posaconazole-based compositions and methods of treating and preventing fungal infections, cancer or metastatic diseases are disclosed. In preferred aspects, the conjugates are PEG-posaconazole conjugates in which the PEG has a molecular weight of about 20,000 daltons.

 
Web www.patentalert.com

< Phosphohalohydrins, process for the production thereof and use thereof

> Thiolesters and uses thereof

> Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics

~ 00563